Bill Gates published an essay this week arguing that the AI transition will be one of the most turbulent periods in modern history. And critically, neither governments nor industry have a plan to manage it. While the essay has far-reaching implications for all industries and humanity generally, three key risk categories emerge for health care and life sciences organizations. It is a useful moment to connect his framing to what is actually showing up in legislative bodies, enforcement actions, and litigation.
On May 1, 2026, Pennsylvania’s State Board of Medicine (or “Petitioner”) filed a lawsuit in the Commonwealth Court of Pennsylvania—alleging that an artificial intelligence (“AI”) chatbot developed by Character Technologies, Inc. (or “Respondent”) engaged in the unlawful practice of medicine.
Recent Updates
- Comment Period Closes on California OHCA’s Proposed Emergency Regulations Expanding Private Equity, Hedge Fund, and MSO Reporting in Health Care Transactions
- DOJ Revises Justice Manual on Non-Binding Guidance and Qui Tam Dismissals: Practical Considerations
- Additional SBA Crackdown on Pandemic-Era Fraud Leads to Program and Loan Suspensions, Possible FCA Enforcement
- Federal Regulatory Views on Cybersecurity and AI Amidst a Growing Threat Landscape
- Remote Monitoring Services Under the 2027 PFS Proposed Rule: Epstein Becker Green Submits Comments to CMS